FDA recall D-0473-2022

Ultra Seal Corporation · Class II · drug

Product

Ephedrine Plus (Ephedrine HCl 25mg, Guaifenesin 200mg) tablets, 24-count bottles, Marketed by: DMD Pharmaceuticals A Division of Dickery Consumer Products, Inc. Noblesville, IN 46060, NDC 65193-320-24

Reason for recall

cGMP deviations

Distribution

Nationwide within the United States

Key facts

Status: Terminated
Initiation date: 2022-01-24
Report date: 2022-02-09
Termination date: 2023-10-16
Voluntary/Mandated: Voluntary: Firm initiated
Location: New Paltz, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0473-2022